Suchergebnisse - "Wei, Guoqing"

PubPharm (8)

1

Recent progress in nanomedicine for enhanced cancer chemotherapy

enthalten in: Theranostics | 2021

von Wei, G. | Wang, Y. | Yang, G. | +2

2

CAR T-cell treatment during the COVID-19 pandemic : Management strategies and challenges

enthalten in: Current research in translational medicine | 2020

von Hu, Y. | Tan Su Yin, E. | Yang, Y. | +17

3

Phototherapy-based combination strategies for bacterial infection treatment

enthalten in: Theranostics | 2020

von Wei, G. | Yang, G. | Wang, Y. | +4

4

Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia

enthalten in: Journal of hematology & oncology | 2017

von Wei, G. | Wang, J. | Huang, H. | +1

5

Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia

enthalten in: Experimental hematology & oncology | 2017

von Wei, G. | Ding, L. | Wang, J. | +2

6

Novel agents and biomarkers for acute lymphoid leukemia

enthalten in: Journal of hematology & oncology | 2013

von Zhao, Y. | Huang, H. | Wei, G.

7

A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome

enthalten in: Journal of hematology & oncology | 2011

von Wei, G. | Ni, W. | Chiao, J. | +3

8

First-line treatment for chronic myeloid leukemia : dasatinib, nilotinib, or imatinib

enthalten in: Journal of hematology & oncology | 2010

von Wei, G. | Rafiyath, S. | Liu, D.

1
[1]